FIGURE 2.
(A). Underlying disease in patients with VT (VT) that was determined to be LVAD associated (“LVAD”) or not LVAD associated (“LVAD-distant”). (B). VT mechanism, i.e., ischemic, non-ischemic dilatative cardiomyopathy (DCM) or other in relation to the respective VT - LVAD association. C and (D). Percentage of patients with VT preceding LVAD implantation in relation to their respective VT–LVAD association (C) or underlying disease entity (D). (E). Histogram of time since LVAD implantation for all patients at end of follow-up. Time-points of EP cases with LVAD associated VT as indicated (black arrow). *p < 0.05 for non-LVAD-association of VT.